Product Information

TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3713 per EA under NDC 65862097603. Its NADAC has been published 433 times since Mar 14, 2018.

TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB

Telmisartan and Hydrochlorothiazide
$0.3713per EA

Strength

12.5; 40 mg/1; mg/1

NDC

65862097603

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208727

On Market Since

12/15/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has been published 433 times since Mar 14, 2018, and over the history we have for it it has declined 80.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3713 per EA
All-time high$2.2627 (Jul 10, 2019)
All-time low$0.2777 (Nov 20, 2024)
52-week high$0.4067
52-week low$0.3484
Median price$1.0575
Average price$1.0892
Largest weekly change+83.5% (Nov 22, 2023)
Weeks tracked433
Tracking sinceMar 14, 2018

Price History

1W

0.0%

1M

+2.4%

3M

+0.8%

6M

-3.0%

1Y

-5.9%

3Y

-27.9%

5Y

-83.2%

All

-80.8%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB, manufactured by Aurobindo Pharma Limited, is $0.3713 per EA (NDC 65862097603), effective Jun 24, 2026.

How has the price of TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB changed over time?

Over the history we have for it, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has declined 80.8%. It has been tracked across 433 weekly CMS publications since Mar 14, 2018.

What are the highest and lowest recorded NADAC prices for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

Since Mar 14, 2018, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has ranged from a low of $0.2777 (Nov 20, 2024) to a high of $2.2627 (Jul 10, 2019), with a median of $1.0575 per EA.

Are there cheaper alternatives to TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

2 NADAC-published products share the same active ingredient, strength, and dosage form as TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB, but none are currently priced below it.

Who manufactures TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB (NDC 65862097603) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.